Asparaginyl-tRNA synthetase

BE0002338ProteinHumansNARS2

Mitochondrial aminoacyl-tRNA synthetase that catalyzes the specific attachment of the asparagine amino acid (aa) to the homologous transfer RNA (tRNA), further participating in protein synthesis (PubMed:25385316). It is acted on by 1 drug in DrugBank.

Gene name
NARS2
UniProtKB entry
Q96I59Swiss-Prot
Cellular location
Mitochondrion matrix
Residues / weight
477 residues · 54,090 Da
Also known as
6.1.1.22 · AsnRS · Asparagine--tRNA ligase, mitochondrial · NARS2

Resolves to

Protein
UniProtQ96I59UniProt nameSYNM_HUMAN
Gene
HGNCHGNC:26274NCBI Gene79731GenBank39644781GeneCardsNARS2
Pharmacology
KEGGhsa:79731
Drugs

What you can answer from here — as of September 03, 2024

1DrugApproved to experimental, with action, bond type and pharmacological action
Sign in
6GO termsFunction, process and component, as structured annotations
Sign in
2Pfam domainsDomain architecture mapped to Pfam families and clans
Sign in
12+ReferencesStructured and connected to the statements they support
Sign in

Which approved drugs act on Asparaginyl-tRNA synthetase, how selective are they, and which programs against it are still in active trials?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In